innoscripta SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	96.19	64.71	39.37	27.27	19.83
Revenue Growth (YoY)	144.31%	64.34%	44.36%	37.56%	-
Cost of Revenue	28.39	19.42	18.19	13.29	8.71
Gross Profit	67.81	45.29	21.19	13.98	11.11
Other Operating Expenses	10.22	7.78	5.48	4.68	3.13
Operating Expenses	10.45	7.96	5.63	4.84	3.26
Operating Income	57.36	37.32	15.56	9.15	7.86
Interest Expense	-0.05	-0.09	-0.08	-0.06	-0.21
Interest & Investment Income	0.21	0.23	0.06	0.12	0.01
Currency Exchange Gain (Loss)	-0.05	-0.05	-0.09	0.03	-0
Pretax Income	57.46	37.41	15.45	9.24	7.66
Income Tax Expense	18.53	12.32	5.18	3.15	2.57
Net Income	38.93	25.09	10.27	6.1	5.09
Net Income to Common	38.93	25.09	10.27	6.1	5.09
Net Income Growth	279.01%	144.27%	68.46%	19.88%	-
Shares Outstanding (Basic)	-	10	10	0	-
Shares Outstanding (Diluted)	-	10	10	0	-
Shares Change (YoY)	-	-	39900.00%	-	-
EPS (Basic)	-	2.51	1.03	243.89	-
EPS (Diluted)	-	2.51	1.03	243.89	-
EPS Growth	-	144.27%	-99.58%	-	-
Free Cash Flow	40.41	20	5.15	8.56	-0.59
Free Cash Flow Per Share	-	2.00	0.52	342.41	-
Dividend Per Share	2.400	2.400	1.600	200.000	-
Dividend Growth	50.00%	50.00%	-99.20%	-	-
Gross Margin	70.49%	69.99%	53.81%	51.27%	56.05%
Operating Margin	59.63%	57.68%	39.52%	33.54%	39.63%
Profit Margin	40.47%	38.78%	26.09%	22.36%	25.65%
Free Cash Flow Margin	42.01%	30.91%	13.08%	31.39%	-2.98%
EBITDA	57.58	37.51	15.71	9.3	7.98
EBITDA Margin	59.86%	57.97%	39.91%	34.10%	40.25%
D&A For EBITDA	0.23	0.18	0.15	0.15	0.12
EBIT	57.36	37.32	15.56	9.15	7.86
EBIT Margin	59.63%	57.68%	39.52%	33.54%	39.63%
Effective Tax Rate	32.25%	32.94%	33.52%	34.04%	33.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.